Droge Ogen Kliniek Nederland
de aandacht en expertise die u verdient

publicaties

meest Recente publicaties

  1. Magno MS, Wolpert LE, Morthen MK, Utheim TP, Hammond CJ, Vehof J. The association between personality and dry eye disease: A large cross-sectional study. Ocul Surf. 2025 Mar 26;37:132-139.

  2. Vehof J, Rhee A, Rossi N, Falchi M, Hammond CJ, Williams FMK. A large hypothesis-free proteomics study investigating serum inflammatory markers as biomarkers of dry eye disease. Ocul Surf. 2025 Apr;36:198-208.

  3. De Lott LB, Kaplan C, Harte S, Clauw DJ, Galor A, Vehof J, Shtein RM. Nociplastic pain among individuals with chronic ocular surface pain: One cause for "pain without stain"? Surv Ophthalmol. 2025 May-Jun;70(3):536-543.

  4. Rhee A, Granville Smith I, Compte R, Vehof J, Nessa A, Wadge S, Freidin MB, Bennett DL, Williams FMK. Quantitative sensory testing and chronic pain syndromes: a cross-sectional study from TwinsUK. BMJ Open. 2024 Sep 3;14(9).

  5. Mysen OMB, Hynnekleiv L, Magnø MS, Vehof J, Utheim TP. Review of Hydroxypropyl Methylcellulose in Artificial Tears for the Treatment of Dry Eye Disease. Acta Ophthalmol. 2024 Dec;102(8):881-896.

  6. Hynnekleiv L, Magno M, Moschowits E, Tonseth KA, Vehof J, Utheim TP: A comparison between hyaluronic acid and other single ingredient eye drops for dry eye, a review. Acta Ophthalmol 2024, 102:25-37.

  7. Fineide F, Magno MS, Khan AZ, Chen X, Vehof J, Utheim TP: Intense pulsed light treatment in meibomian gland dysfunction: Past, present, and future. Acta Ophthalmol 2024, 102:e414-e442.

  8. Fineide F, Magno M, Dahlo K, Kolko M, Heegaard S, Vehof J, Utheim TP: Topical glaucoma medications - Possible implications on the meibomian glands. Acta Ophthalmol 2024.

  9. Schjerven Magno M, Olafsson J, Beining M, Moschowits E, Lagali N, Wolffsohn JS, Craig JP, Vehof J, Dartt DA, Utheim TP: Hot towels: The bedrock of Meibomian gland dysfunction treatment - A review. Cont Lens Anterior Eye 2023, 46:101775.

  10. Nguyen L, Magno MS, Utheim TP, Jansonius NM, Hammond CJ, Vehof J: The relationship between habitual water intake and dry eye disease. Acta Ophthalmol 2023, 101:65-73.

  11. Nguyen L, Magno MS, Utheim TP, Hammond CJ, Vehof J: The relationship between sedentary behavior and dry eye disease. Ocul Surf 2023, 28:11-17.

  12. Morthen MK, Magno MS, Utheim TP, Hammond CJ, Vehof J: The work-related burden of dry eye. Ocul Surf 2023, 28:30-36.

  13. Markoulli M, Ahmad S, Arcot J, Arita R, Benitez-Del-Castillo J, Caffery B, Downie LE, Edwards K, Flanagan J, Labetoulle M, …, Vehof J, …, et al: TFOS Lifestyle: Impact of nutrition on the ocular surface. Ocul Surf 2023, 29:226-271.

  14. Magno MS, Utheim TP, Morthen MK, Snieder H, Jansonius NM, Hammond CJ, Vehof J: The Relationship Between Caffeine Intake and Dry Eye Disease. Cornea 2023, 42:186-193.

  15. Magno MS, Moschowits E, Morthen MK, Beining MW, Jansonius NM, Hammond CJ, Utheim TP, Vehof J: Greater adherence to a mediterranean diet is associated with lower C-reactive protein (CRP) levels, but not to lower odds of having dry eye disease. Ocul Surf 2023, 30:196-203.

  16. Gijs M, Arumugam S, van de Sande N, Webers CAB, Sethu S, Ghosh A, Shetty R, Vehof J, Nuijts R: Pre-analytical sample handling effects on tear fluid protein levels. Sci Rep 2023, 13:1317.

  17. Fineide FA, Tashbayev B, Elgstoen KBP, Sandas EM, Rootwelt H, Hynne H, Chen X, Raeder S, Vehof J, Dartt D, et al: Tear and Saliva Metabolomics in Evaporative Dry Eye Disease in Females. Metabolites 2023, 13.

  18. Asefa NG, Neustaeter A, Vehof J, Nolte IM, Snieder H, Jansonius NM: Development and validation of a questionnaire-based myopia proxy in adults: the LifeLines Cohort Study. Br J Ophthalmol 2023, 107:1035-1042.

  19. Vernhardsdottir RR, Magno MS, Hynnekleiv L, Lagali N, Dartt DA, Vehof J, Jackson CJ, Utheim TP: Antibiotic treatment for dry eye disease related to meibomian gland dysfunction and blepharitis - A review. Ocul Surf 2022, 26:211-221.

  20. Morthen MK, Magno MS, Utheim TP, Snieder H, Jansonius N, Hammond CJ, Vehof J: The vision-related burden of dry eye. Ocul Surf 2022, 23:207-215.

  21. Magno MS, Olafsson J, Beining M, Moschowits E, Lagali N, Wolffsohn JS, Craig JP, Dartt DA, Vehof J, Utheim TP: Chambered warm moist air eyelid warming devices - a review. Acta Ophthalmol 2022, 100:499-510.

  22. Kamoy B, Magno M, Noland ST, Moe MC, Petrovski G, Vehof J, Utheim TP: Video display terminal use and dry eye: preventive measures and future perspectives. Acta Ophthalmol 2022, 100:723-739.

  23. Hynnekleiv L, Magno M, Vernhardsdottir RR, Moschowits E, Tonseth KA, Dartt DA, Vehof J, Utheim TP: Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmol 2022, 100:844-860.

  24. Fjaervoll K, Fjaervoll H, Magno M, Noland ST, Dartt DA, Vehof J, Utheim TP: Review on the possible pathophysiological mechanisms underlying visual display terminal-associated dry eye disease. Acta Ophthalmol 2022, 100:861-877.

  25. Fjaervoll H, Fjaervoll K, Magno M, Moschowits E, Vehof J, Dartt DA, Utheim TP: The association between visual display terminal use and dry eye: a review. Acta Ophthalmol 2022, 100:357-375.

  26. Fineide F, Lagali N, Adil MY, Arita R, Kolko M, Vehof J, Utheim TP: Topical glaucoma medications - Clinical implications for the ocular surface. Ocul Surf 2022, 26:19-49.

  27. Beining MW, Magno MS, Moschowits E, Olafsson J, Vehof J, Dartt DA, Utheim TP: In-office thermal systems for the treatment of dry eye disease. Surv Ophthalmol 2022, 67:1405-1418.

  28. Wolpert LE, Snieder H, Jansonius NM, Utheim TP, Hammond CJ, Vehof J: Medication use and dry eye symptoms: A large, hypothesis-free, population-based study in the Netherlands. Ocul Surf 2021, 22:1-12.

  29. Vehof J, Snieder H, Jansonius N, Hammond CJ: Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in the Netherlands. Ocul Surf 2021, 19:83-93.

  30. Patasova K, Khawaja AP, Tamraz B, Williams KM, Mahroo OA, Freidin M, Solebo AL, Vehof J, Falchi M, Rahi JS, et al: Association Between Medication-Taking and Refractive Error in a Large General Population-Based Cohort. Invest Ophthalmol Vis Sci 2021, 62:15.

  31. Neustaeter A, Vehof J, Snieder H, Jansonius NM: Glaucoma in large-scale population-based epidemiology: a questionnaire-based proxy. Eye (Lond) 2021, 35:508-516.

  32. Mossel E, van Nimwegen JF, Stel AJ, Wijnsma RF, Delli K, van Zuiden GS, Olie L, Vehof J, Los LI, Vissink A, et al: Clinical Phenotyping of Primary Sjogren Syndrome Patients Using Salivary Gland Ultrasonography: Data From the RESULT Cohort. J Rheumatol 2021, 48:717-727.

  33. Morthen MK, Magno MS, Utheim TP, Snieder H, Hammond CJ, Vehof J: The physical and mental burden of dry eye disease: A large population-based study investigating the relationship with health-related quality of life and its determinants. Ocul Surf 2021, 21:107-117.

  34. Magno MS, Utheim TP, Snieder H, Hammond CJ, Vehof J: The relationship between dry eye and sleep quality. Ocul Surf 2021, 20:13-19.

  35. Magno MS, Daniel T, Morthen MK, Snieder H, Jansonius N, Utheim TP, Hammond CJ, Vehof J: The relationship between alcohol consumption and dry eye. Ocul Surf 2021, 21:87-95.

  36. Magno M, Moschowits E, Arita R, Vehof J, Utheim TP: Intraductal meibomian gland probing and its efficacy in the treatment of meibomian gland dysfunction. Surv Ophthalmol 2021, 66:612-622.

  37. Erickson S, Sullivan AG, Abad JC, Alves M, Barabino S, Craig JP, Eid M, Farrant S, Gomes JAP, Heydenrych L, …, Vehof J, …, et al: TFOS: Unique challenges and unmet needs for the management of ocular surface diseases throughout the world. Ocul Surf 2021, 22:242-244.

  38. Arends S, de Wolff L, van Nimwegen JF, Verstappen G, Vehof J, Bombardieri M, Bowman SJ, Pontarini E, Baer AN, Nys M, et al: Composite of Relevant Endpoints for Sjogren's Syndrome (CRESS): development and validation of a novel outcome measure. Lancet Rheumatol 2021, 3:e553-e562.

  39. Ansari AS, Vehof J, Hammond CJ, Bremner FD, Williams KM: Evidence That Pupil Size and Reactivity Are Determined More by Your Parents Than by Your Environment. Front Neurol 2021, 12:651755.

  40. Vehof J, Utheim TP, Bootsma H, Hammond CJ: Advances, limitations and future perspectives in the diagnosis and management of dry eye in Sjogren's syndrome. Clin Exp Rheumatol 2020, 38 Suppl 126:301-309.

  41. Ramos-Casals M, Brito-Zeron P, Bombardieri S, Bootsma H, De Vita S, Dorner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A,…, Vehof J, …, et al: EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies. Ann Rheum Dis 2020, 79:3-18.

  42. Erickson S, Sullivan AG, Barabino S, Begovic E, Benitez-Del-Castillo JM, Bonini S, Borges JS, Brzheskiy V, Bulat N, Cerim A, …., Vehof J, …, et al: TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseases. Ocul Surf 2020, 18:936-962.

  43. Bazeer S, Jansonius N, Snieder H, Hammond C, Vehof J: The relationship between occupation and dry eye. Ocul Surf 2019, 17:484-490.

  44. Vehof J, Sillevis Smitt-Kamminga N, Nibourg SA, Hammond CJ: Sex differences in clinical characteristics of dry eye disease. Ocul Surf 2018, 16:242-248.

  45. Vehof J, Sillevis Smitt-Kamminga N, Nibourg SA, Hammond CJ: Predictors of Discordance between Symptoms and Signs in Dry Eye Disease. Ophthalmology 2017, 124:280-286.

  46. Vehof J, Hysi PG, Hammond CJ: A Metabolome-Wide Study of Dry Eye Disease Reveals Serum Androgens as Biomarkers. Ophthalmology 2017, 124:505-511.

  47. Van Deemter M, Bank RA, Vehof J, Hooymans JM, Los LI: Factors Associated with Pentosidine Accumulation in the Human Vitreous. Retina 2017, 37:770-777.

  48. Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, et al: TFOS DEWS II Epidemiology Report. Ocul Surf 2017, 15:334-365.

  49. Vehof J, Sillevis Smitt-Kamminga N, Kozareva D, Nibourg SA, Hammond CJ: Clinical Characteristics of Dry Eye Patients With Chronic Pain Syndromes. Am J Ophthalmol 2016, 162:59-65 e52.

  50. Vehof J, Sillevis Smitt-Kamminga N, Kozareva D, Nibourg SA, Hammond CJ: Clinical Characteristics of Dry Eye Patients With Chronic Pain Syndromes. Am J Ophthalmol 2016, 166:203-204.

  51. Van de Put MA, Vehof J, Hooymans JM, Los LI: Postoperative metamorphopsia in macula-off rhegmatogenous retinal detachment: associations with visual function, vision related quality of life, and optical coherence tomography findings. PLoS One 2015, 10:e0120543.

  52. Burri A, Ogata S, Vehof J, Williams F: Chronic widespread pain: clinical comorbidities and psychological correlates. Pain 2015, 156:1458-1464.

  53. Vehof J, Zavos HMS, Lachance G, Hammond CJ, Williams FMK: Shared genetic factors underlie chronic pain syndromes. Pain 2014, 155:1562-1568.

  54. Vehof J, Williams FM: Genetic predisposition to chronic pain: from evolutionary advantage to a debilitating disease spectrum? Pain Manag 2014, 4:381-383.

  55. Vehof J, Wang B, Kozareva D, Hysi PG, Snieder H, Hammond CJ: The heritability of dry eye disease in a female twin cohort. Invest Ophthalmol Vis Sci 2014, 55:7278-7283.

  56. Vehof J, Kozareva D, Hysi PG, Hammond CJ: Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol 2014, 98:1712-1717.

  57. Vehof J, Kozareva D, Hysi PG, Harris J, Nessa A, Williams FK, Bennett DL, McMahon SB, Fahy SJ, Direk K, et al: Relationship between dry eye symptoms and pain sensitivity. JAMA Ophthalmol 2013, 131:1304-1308.